Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) (Statement) - USD ($) $ in Thousands	Total	Balances at December 31, 2020 (as previously reported)	Retroactive application of the recapitalization due to Merger	[1]	Common Stock	Common Stock Balances at December 31, 2020 (as previously reported)	Common Stock Retroactive application of the recapitalization due to Merger	[1]	Additional Paid-In Capital	Accumulated Other Comprehensive Income	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2020	75,495,000	41,587,000	33,908,000
Beginning balance at Dec. 31, 2020	$ 143,086
Ending balance (in shares) at Mar. 31, 2021	75,495,000
Ending balance at Mar. 31, 2021	$ 143,086
Beginning balance (in shares) at Dec. 31, 2020					5,020,000	2,765,000	2,255,000
Beginning balance at Dec. 31, 2020	(106,135)				$ 1				$ 1,611	$ 0	$ (107,747)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	225								225
Proceeds from option exercises (shares)					919,000
Proceeds from option exercises	332								332
Net income (loss)	(6,826)										(6,826)
Ending balance (in shares) at Mar. 31, 2021					5,939,000
Ending balance at Mar. 31, 2021	$ (112,404)				$ 1				2,168	0	(114,573)
Beginning balance (in shares) at Dec. 31, 2020	75,495,000	41,587,000	33,908,000
Beginning balance at Dec. 31, 2020	$ 143,086
Ending balance (in shares) at Sep. 30, 2021	75,495,000
Ending balance at Sep. 30, 2021	$ 143,086
Beginning balance (in shares) at Dec. 31, 2020					5,020,000	2,765,000	2,255,000
Beginning balance at Dec. 31, 2020	(106,135)				$ 1				1,611	0	(107,747)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(29,233)
Ending balance (in shares) at Sep. 30, 2021					8,342,000
Ending balance at Sep. 30, 2021	$ (132,210)				$ 1				4,769	0	(136,980)
Beginning balance (in shares) at Mar. 31, 2021	75,495,000
Beginning balance at Mar. 31, 2021	$ 143,086
Ending balance (in shares) at Jun. 30, 2021	75,495,000
Ending balance at Jun. 30, 2021	$ 143,086
Beginning balance (in shares) at Mar. 31, 2021					5,939,000
Beginning balance at Mar. 31, 2021	(112,404)				$ 1				2,168	0	(114,573)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	690								690
Proceeds from option exercises (shares)					2,214,000
Proceeds from option exercises	806								806
Net income (loss)	(7,715)										(7,715)
Ending balance (in shares) at Jun. 30, 2021					8,153,000
Ending balance at Jun. 30, 2021	$ (118,623)				$ 1				3,664	0	(122,288)
Ending balance (in shares) at Sep. 30, 2021	75,495,000
Ending balance at Sep. 30, 2021	$ 143,086
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	998								998
Proceeds from option exercises (shares)					189,000
Proceeds from option exercises	107								107
Net income (loss)	(14,692)										(14,692)
Ending balance (in shares) at Sep. 30, 2021					8,342,000
Ending balance at Sep. 30, 2021	$ (132,210)				$ 1				4,769	0	(136,980)
Beginning balance (in shares) at Dec. 31, 2021	0
Beginning balance at Dec. 31, 2021	$ 0
Ending balance (in shares) at Mar. 31, 2022	0
Ending balance at Mar. 31, 2022	$ 0
Beginning balance (in shares) at Dec. 31, 2021	114,991,026				114,991,000
Beginning balance at Dec. 31, 2021	$ 121,599				$ 11				323,666	0	(202,078)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	7,557								7,557
Proceeds from option exercises (shares)					723,000
Proceeds from option exercises	131				$ 1				130
Net income (loss)	44,894										44,894
Ending balance (in shares) at Mar. 31, 2022					115,714,000
Ending balance at Mar. 31, 2022	$ 174,181				$ 12				331,353	0	(157,184)
Beginning balance (in shares) at Dec. 31, 2021	0
Beginning balance at Dec. 31, 2021	$ 0
Ending balance (in shares) at Sep. 30, 2022	0
Ending balance at Sep. 30, 2022	$ 0
Beginning balance (in shares) at Dec. 31, 2021	114,991,026				114,991,000
Beginning balance at Dec. 31, 2021	$ 121,599				$ 11				323,666	0	(202,078)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Proceeds from option exercises (shares)	1,583,000
Net income (loss)	$ 15,533
Ending balance (in shares) at Sep. 30, 2022	116,574,031				116,574,000
Ending balance at Sep. 30, 2022	$ 158,603				$ 12				344,984	152	(186,545)
Beginning balance (in shares) at Mar. 31, 2022	0
Beginning balance at Mar. 31, 2022	$ 0
Ending balance (in shares) at Jun. 30, 2022	0
Ending balance at Jun. 30, 2022	$ 0
Beginning balance (in shares) at Mar. 31, 2022					115,714,000
Beginning balance at Mar. 31, 2022	174,181				$ 12				331,353	0	(157,184)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	7,103								7,103
Proceeds from option exercises (shares)					538,000
Proceeds from option exercises	369								369
Net income (loss)	(5,833)										(5,833)
Foreign currency translation	27									27
Ending balance (in shares) at Jun. 30, 2022					116,252,000
Ending balance at Jun. 30, 2022	$ 175,847				$ 12				338,825	27	(163,017)
Ending balance (in shares) at Sep. 30, 2022	0
Ending balance at Sep. 30, 2022	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	5,981								5,981
Proceeds from option exercises (shares)					322,000
Proceeds from option exercises	178								178
Net income (loss)	(23,528)										(23,528)
Foreign currency translation	$ 125									125
Ending balance (in shares) at Sep. 30, 2022	116,574,031				116,574,000
Ending balance at Sep. 30, 2022	$ 158,603				$ 12				$ 344,984	$ 152	$ (186,545)

[1] Historical shares and capital amounts have been retroactively adjusted for reverse recapitalization as described in Note 1 “Company Background and Basis of Presentation” to the audited financial statements included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021.